Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $1.62 Analyst target: $262.50 Upside: 16103.70%
Jaguar Health, Inc., a commercial-stage pharmaceutical company, focuses on developing prescription drugs for people and animals with gastrointestinal upset, specifically chronic debilitating diarrhea. The company is headquartered in San Francisco, California.
See the full interactive analysis & chart →Informational only — not investment advice.